Indicators

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >

2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs

January 04, 2024

10 Health Care Stocks Whale Activity In Today's Session

January 02, 2024

3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies

December 27, 2023

Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential

December 22, 2023

New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment

December 22, 2023

Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach

December 19, 2023

Where Ionis Pharmaceuticals Stands With Analysts

November 17, 2023

Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat

November 02, 2023

Analyst Expectations for Ionis Pharmaceuticals's Future

October 23, 2023

Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?

October 17, 2023

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023

September 29, 2023

Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges

September 27, 2023

Analyst Expectations for Ionis Pharmaceuticals's Future

September 27, 2023

Why Ionis Pharmaceuticals Stock Popped Today

September 26, 2023

Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action

September 26, 2023

The 7 Most Hated Stocks by Institutional Traders

September 20, 2023

Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope

September 07, 2023

Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports

August 07, 2023

Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook

July 31, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023

July 31, 2023

Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday

July 31, 2023

Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment

July 03, 2023

Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst

June 12, 2023

Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'

June 07, 2023

Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday

June 07, 2023

Analyst Expectations for Ionis Pharmaceuticals's Future

June 07, 2023

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023

May 04, 2023

Recap: Ionis Pharmaceuticals Q1 Earnings

May 03, 2023

Ionis Pharmaceuticals's Earnings Outlook

May 02, 2023

Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA

April 26, 2023

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.